- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 290878, 9 pages
CD49b, a Major Marker of Regulatory T-Cells Type 1, Predicts the Response to Antiviral Therapy of Recurrent Hepatitis C after Liver Transplantation
1Centre de Transplantation Hépatique, Pôle Digestif, APHP, Hôpital Saint Antoine, 184 Rue de Faubourg Saint Antoine, 75012 Paris, France
2UPMC Université Paris 6, Inserm, UMR_S938, Centre de Recherche Saint Antoine, 75012 Paris, France
3UMR 8161, Institut de Biologie de Lille, 1 Rue du Professeur Calmette, 59028 Lille, France
4Unité de Biostatistique, Hôpital Cochin, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France
Received 30 April 2013; Revised 8 October 2013; Accepted 14 October 2013; Published 19 January 2014
Academic Editor: Kenichi Harada
Copyright © 2014 Stenard Fabien et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- F. Negro and A. Hadengue, “Therapy of chronic hepatitis B,” Revue Medicale Suisse, vol. 2, no. 77, pp. 1981–1985, 2006.
- S. M. Kamal, C. S. Graham, Q. He et al., “Kinetics of intrahepatic hepatitis C virus (HCV)—specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis,” Journal of Infectious Diseases, vol. 189, no. 7, pp. 1140–1150, 2004.
- M. P. Curry, “Hepatitis B and hepatitis C viruses in liver transplantation,” Transplantation, vol. 78, no. 7, pp. 955–963, 2004.
- E. Velidedeoglu, K. C. Mange, A. Frank et al., “Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCV- recipients,” Transplantation, vol. 77, no. 12, pp. 1834–1842, 2004.
- M. Berenguer, M. Prieto, F. San Juan, et al., “Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients,” Hepatology, vol. 36, article 202, 2002.
- R. Thimme, D. Oldach, K. Chang, C. Steiger, S. C. Ray, and F. V. Chisari, “Determinants of viral clearance and persistence during acute hepatitis C virus infection,” Journal of Experimental Medicine, vol. 194, no. 10, pp. 1395–1406, 2001.
- J. T. Gerlach, H. M. Diepolder, M.-C. Jung et al., “Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C,” Gastroenterology, vol. 117, no. 4, pp. 933–941, 1999.
- S. Tsai, Y. Liaw, M. Chen, C. Huang, and G. C. Kuo, “Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity,” Hepatology, vol. 25, no. 2, pp. 449–458, 1997.
- M. Murata, S. Nabeshima, N. Maeda, H. Nakashima, S. Kashiwagi, and J. Hayashi, “Increased frequency of IFN-γ-producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C,” Journal of Medical Virology, vol. 67, no. 2, pp. 162–170, 2002.
- A. O'Garra and P. Vieira, “Regulatory T cells and mechanisms of immune system control,” Nature Medicine, vol. 10, no. 8, pp. 801–805, 2004.
- S. Sakaguchi, N. Sakaguchi, J. Shimizu et al., “Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance,” Immunological Reviews, vol. 182, pp. 18–32, 2001.
- S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, “Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases,” Journal of Immunology, vol. 155, no. 3, pp. 1151–1164, 1995.
- J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi, “Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance,” Nature Immunology, vol. 3, no. 2, pp. 135–142, 2002.
- B. Birebent, R. Lorho, H. Lechartier et al., “Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression,” European Journal of Immunology, vol. 34, no. 12, pp. 3485–3496, 2004.
- S. Hori, T. Nomura, and S. Sakaguchi, “Control of regulatory T cell development by the transcription factor Foxp3,” Science, vol. 299, no. 5609, pp. 1057–1061, 2003.
- M. E. Morgan, J. H. M. van Bilsen, A. M. Bakker et al., “Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans,” Human Immunology, vol. 66, no. 1, pp. 13–20, 2005.
- H. Groux, A. O'Garra, M. Bigler et al., “A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis,” Nature, vol. 389, no. 6652, pp. 737–742, 1997.
- M. Rahmoun, A. Foussat, H. Groux, J. Pène, H. Yssel, and P. Chanez, “Enhanced frequency of CD18- and CD49b-expressing T cells in peripheral blood of asthmatic patients correlates with disease severity,” International Archives of Allergy and Immunology, vol. 140, no. 2, pp. 139–149, 2006.
- H. L. Weiner, “Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells,” Immunological Reviews, vol. 182, pp. 207–214, 2001.
- R. Cabrera, Z. Tu, Y. Xu et al., “An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection,” Hepatology, vol. 40, no. 5, pp. 1062–1071, 2004.
- S. M. Rushbrook, S. M. Ward, E. Unitt et al., “Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection,” Journal of Virology, vol. 79, no. 12, pp. 7852–7859, 2005.
- T. Boettler, H. C. Spangenberg, C. Neumann-Haefelin et al., “T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection,” Journal of Virology, vol. 79, no. 12, pp. 7860–7867, 2005.
- A. J. MacDonald, M. Duffy, M. T. Brady et al., “CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons,” Journal of Infectious Diseases, vol. 185, no. 6, pp. 720–727, 2002.
- M. M. Velásquez-Lopera, V. L. Eaton, N. M. Lerret et al., “Induction of transplantation tolerance by allogeneic donor-derived CD4+CD25+Foxp3+ regulatory T cells,” Transplant Immunology, vol. 19, no. 2, pp. 127–135, 2008.
- O. Joffre, T. Santolaria, D. Calise et al., “Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes,” Nature Medicine, vol. 14, no. 1, pp. 88–92, 2008.
- R. Zeiser, V. H. Nguyen, A. Beilhack et al., “Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production,” Blood, vol. 108, no. 1, pp. 390–399, 2006.
- A. Demirkiran, A. Kok, J. Kwekkeboom et al., “Low circulating regulatory T-cell levels after acute rejection in liver transplantation,” Liver Transplantation, vol. 12, no. 2, pp. 277–284, 2006.
- F. Stenard, C. Nguyen, K. Cox et al., “Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients,” Pediatric Transplantation, vol. 13, no. 1, pp. 70–80, 2009.
- A. Carpentier, F. Conti, F. Stenard et al., “Increased expression of regulatory tr1 cells in recurrent hepatitis C after liver transplantation,” American Journal of Transplantation, vol. 9, no. 9, pp. 2102–2112, 2009.
- Y. Calmus, C. Duvoux, G. Pageaux, et al., “Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNalpha-2a plus ribavirin,” Journal of Hepatology, vol. 57, p. 564, 2012.
- A. Carpentier, F. Conti, M. Carrière et al., “Analysis of gene transcription in sera during chronic hepatitis C infection,” Journal of Medical Virology, vol. 81, no. 3, pp. 473–480, 2009.
- X. Zhou, S. Bailey-Bucktrout, L. T. Jeker, and J. A. Bluestone, “Plasticity of CD4+ FoxP3+ T cells,” Current Opinion in Immunology, vol. 21, no. 3, pp. 281–285, 2009.
- A. H. Banham, “Cell-surface IL-7 receptor expression facilitates the purification of FOXP3+ regulatory T cells,” Trends in Immunology, vol. 27, no. 12, pp. 541–544, 2006.
- L. Charbonnier, L. M. Van Duivenvoorde, F. Apparailly et al., “Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells,” Journal of Immunology, vol. 177, no. 6, pp. 3806–3813, 2006.
- R. J. Firpi, M. F. Abdelmalek, C. Soldevila-Pico et al., “One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection,” Liver Transplantation, vol. 10, no. 10, pp. 1240–1247, 2004.
- M. Akiyama, T. Ichikawa, H. Miyaaki et al., “Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C,” Intervirology, vol. 53, no. 3, pp. 154–160, 2010.
- C. Feray, L. Caccamo, G. J. M. Alexander et al., “European collaborative study on factors influencing outcome after liver transplantation for hepatitis C,” Gastroenterology, vol. 117, no. 3, pp. 619–625, 1999.
- L. M. Forman, J. D. Lewis, J. A. Berlin, H. I. Feldman, and M. R. Lucey, “The association between hepatitis C infection and survival after orthotopic liver transplantation,” Gastroenterology, vol. 122, no. 4, pp. 889–896, 2002.
- J. Dumortier, J. Scoazec, P. Chevallier, and O. Boillot, “Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination,” Journal of Hepatology, vol. 40, no. 4, pp. 669–674, 2004.
- H. Rodriguez-Luna, A. Khatib, P. Sharma et al., “Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon α2b and ribavirin: an open-label series,” Transplantation, vol. 77, no. 2, pp. 190–194, 2004.
- T. Manigold and V. Racanelli, “T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies,” The Lancet Infectious Diseases, vol. 7, no. 12, pp. 804–813, 2007.
- S. Smyk-Pearson, L. Golden-Mason, J. Klarquist et al., “Functional suppression by FoxP3+CD4+CD25 high regulatory T cells during acute hepatitis C virus infection,” Journal of Infectious Diseases, vol. 197, no. 1, pp. 46–57, 2008.
- L. Charbonnier, W. G. H. Han, J. Quentin et al., “Adoptive transfer of IL-10-secreting CD4+CD49b+ regulatory T cells suppresses ongoing arthritis,” Journal of Autoimmunity, vol. 34, no. 4, pp. 390–399, 2009.